Tim from Auscap is one of the few fundies with a great track record, so his thesis on RMD is more meaningful than most...

It looks like Dexcom's large drop in the US is rubbing off on other stocks that are on the coalface of GLP-1 disruption, including ResMed, which dropped 5% in Friday's US session. More muted drop here today, but it feels like deja vu from the past year or so to me :)